2022 ZERO SUMMIT:
The 2022 ZERO Prostate Cancer Summit is an empowering series of educational sessions, advocacy initiatives and awards. Over the course of three days, the 2022 ZERO Prostate Cancer Summit presented a series of live, interactive educational sessions. Topics ranged from Sexual Health to PSMA Therapeutics. The Summit also featured our keynote speaker, Jay Jay French, the founder of “Twisted Sister” and a prostate cancer survivor. Click here to learn more about the 2022 ZERO Summit sessions, or watch the replay playlist below:
2022 ZERO Summit
MOST RECENT WEBINARS:
The Future of Radiation in Prostate Cancer
The annual American Society for Radiation Oncology (ASTRO) meeting, held in October, delivers the top science and education related to the field of radiation oncology. Cutting edge artificial intelligence in radiation, clinical trials, preventing and mitigating radiation and toxicity, and equity and access in radiation oncology are only a few of the exciting topics presented.
The Promise Registry: How Genetic Factors Impact Prostate Cancer
We know that prostate cancer may be written in some genetics, but so are instructions for discovering new treatments and understanding family risk. Join Dr. Heather Cheng and Dr. Channing Paller live as they talk about the PROMISE Study Registry, a research study led by physicians from Johns Hopkins University and University of Washington. This observational study enables men with prostate cancer to find out if they have genetic factors that may influence their disease and treatment options.
Prostate Cancer & the Unique Needs of the LGBTQIA+ Community
Join ZERO and Dr. Anne Katz, certified sexuality counselor and Clinical Nurse Specialist, for this webinar to hear her discuss the unique issues and experiences that members of the LGBTQIA+ community can have with prostate cancer, from diagnosis through survivorship.
Genetics, the PROMISE Study, & Prostate Cancer: A Town Hall
Sponsored by Myriad Genetics and the PROMISE Study
This webinar will present you with information on new treatments and help you understand your family risk through genetics. Join Rob Finch, Director of Urology Medical Affairs at Myriad Genetics, and Dr. Channing Paller, Associate Professor of Oncology and Urology at Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, as they discuss genetics in prostate cancer and the PROMISE Study Registry, a new research study led by physicians from Johns Hopkins University and University of Washington.
Prostate Health: Early Detection, Treatment, & Resources
Tune in for this special webinar featuring prostate health expert Dr. Alexander Engelman, who will review risks, signs, and symptoms of prostate cancer, early detection education, treatment options, and family support resources.
Genetic Testing in Prostate Cancer with Rob Finch
Meet Rob Finch, Director of Urology Medical Affairs at Myriad Genetic Laboratories. Rob will be answering questions about who should get genetic testing, when testing should begin, and how testing can impact treatment decisions.
For more information, visit https://prolaris.com/genetic-testing/zero22.
Precision Medicine and the Future of Prostate Cancer
Sponsored by POINT Biopharma
Join Shelby Moneer and Dr. Kerry Schaffer for a special ZERO Live! on Precision Medicine and the Future of Prostate Cancer. Visit splashtrial.com to learn more about the SPLASH trial, investigating a potential treatment for metastatic Castration-Resistant Prostate Cancer.
Side Effects of Prostate Cancer Treatments, Risk Mitigation, and Treatment Advances
Prostate cancer treatments can bring a variety of side effects. Sexual function, bowel function, and urinary function may be impacted. Thankfully, new side effect risk reduction and treatment strategies exist. This two part series covered signs, symptoms, and treatment options for erectile dysfunction and incontinence with Dr. Michael Granieri on May 10th, followed by May 19th, with Dr. Albert Chang discussing prostate cancer and treatment options, including radiation with SpaceOAR Hydrogel.
2022 ASCO GU Symposium Research Updates with Dr. Alexandra Sokolova
The American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) Annual Meeting brings together thousands of clinicians, researchers, patients, and patient advocates while serving up educational and scientific sessions throughout the 3 day meeting. Join us as Dr. Alexandra Sokolova from Oregon Health and Science University shares exciting and timely prostate cancer research and treatment findings and provides an update on emerging early cancer detection technology from the 2022 Annual ASCO GU Meeting.
PSMA PET Imaging for Prostate Cancer with Dr. Tomasz Beer
Sponsored by Lantheus Medical Imaging
Join Shelby Moneer and Dr. Tomasz Beer for a special virtual discussion on PSMA PET Imaging for Prostate Cancer and how it can provide more precise testing to better guide prostate cancer treatment decisions.
Conversations with Caregivers: A Town Hall
Caregivers play a pivotal role in the prostate cancer journey. ZERO’s Vice President of Patient Programs and Education, Shelby Moneer and a panel of caregivers engage in a casual conversation, sharing their experiences.
A Town Hall Conversation with ZERO’s Racial Disparities Task Force
Sponsored by Pfizer, AstraZeneca & Janssen
Black men are more likely to be diagnosed with prostate cancer and to die from the disease than white men. Recent research suggests that these differences in health outcomes are likely caused by several factors within the U.S. healthcare system including access to care, insurance status, racial biases, and distrust in the medical system – it cannot be solely explained by genetic differences.
Our Racial Disparities Task Force Co-Chairs, Robert Ginyard and Dr. Kelvin Moses were joined by ZERO’s new Vice President of Health Equity, Dr. Reggie Tucker-Seeley to discuss the progress that has been made since the launch of the Task Force and the road map forward.
What Veterans Need to Know About Prostate Cancer and How to Get Care in Their Community
Sponsored by Intuitive Surgical
Veterans are a high-risk population for prostate cancer, with an incidence rate that is twice that of the general population. It is critical that we protect our protectors. Join this educational webinar and hear from a physician, VA representative, and an elected official about what you should know about your risk for this disease, and how to access prostate cancer screening and treatment within the Veterans Health Administration or through the Community Care Network. A prostate cancer patient will share his story and the importance of Veterans taking an active role in understanding available support resources and treatment decision-making.
ASCO 2021 in Prostate Cancer and Early Detection
The American Society of Clinical Oncology (ASCO) Annual Meeting brings together tens of thousands of clinicians, researchers, patients, and patient advocates while serving up hundreds of educational and scientific sessions throughout the 5 day meeting. Join us as we welcome Dr. Tomasz Beer from Oregon Health and Science University as he shares the most exciting and timely prostate cancer research and treatment findings and provides an update on emerging early cancer detection technology from the 2021 Annual ASCO Meeting.
Understanding Common Side Effects of Prostate Cancer Treatment
Prostate cancer treatments can bring a variety of side effects. Sexual function, bowel function, and urinary function may be impacted. Thankfully, new side effect risk reduction and treatment strategies exist. Join Dr. Arnold Bullock and Dr. Scot Ackerman as they provide an overview of prostate cancer side effect risk reduction and treatment advances that improve the lives of those impacted by prostate cancer.
Clinical Trial Diversity: A Physician and Patient Perspective
As prostate cancer treatment becomes more sophisticated and personalized, the lack of diversity in clinical trials can make it particularly challenging to understand drug safety and efficacy. Dr. Laurence H. Belkoff, DO, MSc. FACOS is joined by a patient who is currently enrolled in a clinical trial discuss dynamics behind participation in a clinical trial as a person of color, and the importance of clinical trial diversity.
Financing the Fight of Your Life: Financial Assistance for Prostate Cancer
As a result of the COVID-19 pandemic, more patients are experiencing job and health care loss, difficulties making ends meet, and challenges in affording their treatment costs. In this free webinar, ZERO’s Vice President of Patient Programs and Education, Shelby Moneer, discussed ZERO’s free support offerings, including our case management program, ZERO360, and ZERO’s new comprehensive financial resources mini-site. She was joined by Monica Bryant, COO of Triage Cancer, as well as Jasmine Pugh, a ZERO360 case manager, shared insight and guidance into navigating the financial burdens of the prostate cancer journey.
ZERO Virtual Town Hall
ZERO hosted its first-ever Virtual Town Hall to address the issues most pressing for prostate cancer patients and their families. It featured a distinguished panel of medical professionals, patients, and caregivers to discuss the latest challenges, treatments, and other news that is impacting patient lives. The event featured questions and answers in real-time from our online audience throughout to make this event interactive and informative. Speakers included: Dr. Elisabeth Heath, MD, FACP, Dr. Kelvin Moses, M.D., Ph.D., John Vaughn, and Vivian Avery.
ZERO’s 2022 Health Equity Symposium:
The 2nd Annual Health Equity Symposium took place on November 5 and the playback can be accessed below. 2022’s event picked up where the inaugural Racial Disparities Symposium left off, addressing the status of prostate cancer disparities and what we can do to eliminate them. Click the videos below to hear from the researchers, healthcare providers, patients/survivors, and community members committed to achieving prostate cancer health equity.
2022 Health Equity Symposium
Paradigm Shift in Prostate Cancer Disease Management
Watch the live recording of this webinar to learn about the importance of prostate-specific antigen (PSA) screening for early detection, treatment decisions, and survivorship. Our speakers will also discuss new guidelines for elevated PSAs and a promising clinical trial on focal therapy. Speakers include: Dr. John Feller, M.D., Bernadette Greenwood, MSc., RT(R)(MR)(ARRT), and Dr. Jeffrey Herz, M.D.
Health Disparities in Prostate Cancer for Black Men
Urologist Dr. Kelvin Moses and prostate cancer survivor Robert Ginyard discuss the historic disparities and prostate cancer, and what can be done to eliminate these drastic differences, including the promise of immunotherapy.
“Understanding Risk Reduction and Treatment Options for Erectile Dysfunction & Other Common Side Effects of Prostate Cancer”
Many prostate cancer patients face challenges with sexual intimacy following their cancer treatment. This webinar provides information about reducing, minimizing, and treating some of the side effects caused by prostate cancer and their treatments. ZERO’s President and CEO Jamie Bearse led the discussion with Dr. Edward M. Soffen, a radiation oncologist at the Rutgers University School of Medicine, and Dr. Gary S. Karlin, a urologist at New Jersey Urology. This webinar is brought to you with support from Boston Scientific. (June 9, 2020)
What You Need to Know About Androgen Deprivation Therapy
In this webinar, Dr. Alicia Morgans, Associate Professor at the The Feinberg School of Medicine at Northwestern University and Chair of ZERO’s Medical Advisory Board addresses how ADT is used to treat men with prostate cancer. Dr. Morgans also discusses who can benefit from ADT, how to manage side effects, and what questions to ask your doctor. This webinar is brought to you with support from Ferring Pharmaceuticals. (May 16, 2019)
The Latest on Prostate Cancer and Bone Health
In this program, Benjamin Lowentritt, M.D., F.A.C.S., Medical Director of the Prostate Cancer Care Program at Chesapeake Urology Associates, will address how prostate cancer can affect bone health and what treatments are available both to treat bone metastases and address bone loss as a side effect of prostate cancer treatment. He will also discuss how to stay informed and involved in your treatment and what questions to ask your doctor.
New Decision Tool for Prostate Cancer Patients: Is Chemotherapy or Hormone Therapy Right for Me?
Identified biomarker (ARV-7) can help patients and their doctors decide between chemotherapy and a second hormone therapy. Discover why this biomarker aids in optimizing prostate cancer outcomes and learn when and where in the prostate cancer journey to use this decision making tool. Featuring Dr. Steven E. Canfield, Chief, Division of Urology at the University of Texas Medical School at Houston.
Sponsors: Sanofi, Genomic Health
Education Video Library
Whether you’re newly diagnosed with prostate cancer, dealing with side effects, or learning to navigate as a survivor, ZERO’s educational videos can help you learn about your options. Visit our YouTube page to share the videos and help raise awareness.
Please find additional videos under the “Playlist” icon in the top left-hand corner.